Morningstar Investor users sign in here.

Video

Square: Stock of the week

Square's Bitcoin purchase is more marketing than operations

Mentioned: Block Inc (SQ)


Andrew Willis: Earlier this year, Square (SQ) decided to buy an additional 170 million US dollars worth of Bitcoin, after the 50 million it bought in October. Why? And what should investors make of the purchases? Were they for any actual operational purpose?

Probably not. While the payment processor allows the purchase and sale of bitcoin through its mobile payment app, we think it was just a sign of enthusiasm – which we note is shared with CEO Jack Dorsey…

Still, the company is participating in the popularity of Bitcoin as a broker through Cash App, and that hints at a key success factor in person-to-person payments generally… It’s a business we see with high growth potential and as operating separately from Square’s small merchant solutions, whose growth could be interrupted by uncertain macroeconomic conditions.

Senior equity analyst Brett Horn appreciates the company’s efforts to build out its consumer business surrounding Cash App. It might need it. Square’s merchant business is a niche segment with high pricing and constrained margins. Sitting at around a 160 per cent premium to our fair value at the moment, we believe investors might be expecting an overly optimistic scenario ahead…

We do appreciate how difficult it is to value such a highly scalable business that’s still seeing strong growth – but with micro-merchants, the company’s been creating, rather than stealing market share. With person-to-person payments, however, it looks like Cash App is positioning itself as a survivor in what we see as a winner-take-all environment.

For Morningstar, I’m Andrew Willis. 

 

 



© 2023 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This report has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or New Zealand wholesale clients of Morningstar Research Ltd, subsidiaries of Morningstar, Inc. Any general advice has been provided without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide at www.morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782.

More from Morningstar

Bank results: the winners and losers
Video

Bank results: the winners and losers

Morningstar analyst Nathan Zaia explains how the banks did and what the future holds.
How to deal with financial stress
Video

How to deal with financial stress

More high-income earners are now also experiencing financial stress. We go through practical ways to reduce it
UniSuper CIO John Pearce on why the 60/40 portfolio is far from dead
Video

UniSuper CIO John Pearce on why the 60/40 portfolio is far from dead

The $130 Billion SuperFund Manager also talks about how he sees risk, his recent investments, and why history isn’t a good guide to the future.
Incitec Pivot: explosive upside ahead?
Video

Incitec Pivot: explosive upside ahead?

Morningstar analyst Mark Taylor believes imminent growth in explosives earnings could lift sentiment.
Why Morningstar see opportunities in coal stocks
Video

Why Morningstar see opportunities in coal stocks

Analyst Jon Mills explains why he’s recently increased fair value estimates for Australian coal companies.
Is the sharp fall in ResMed's share price justified?
Video

Is the sharp fall in ResMed's share price justified?

The potential for weight loss drugs to impact the sleep apnea giant has weighed on the share price, though Morningstar analyst Shane Ponraj thinks...